EU Approval Of Mesenchymal Stromal Cell Therapy Manufacturing Protocol Using nLiven Human Platelet Lysate For A Phase 1B Clinical Trial
INDIANAPOLIS and GALWAY, Ireland, July 10, 2020 /PRNewswire/ — The Centre for Cell Manufacturing Ireland (CCMI) at the National University of Ireland Galway (NUI Galway) and Sexton Biotechnologies today announced the approval by an EU Regulatory Authority of a protocol for the…
Comments Off on EU Approval Of Mesenchymal Stromal Cell Therapy Manufacturing Protocol Using nLiven Human Platelet Lysate For A Phase 1B Clinical Trial